These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 38967906)

  • 1. Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder.
    Belnap MA; McManus KR; Grodin EN; Ray LA
    Pharmaceut Med; 2024 Jul; 38(4):291-302. PubMed ID: 38967906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.
    Kranzler HR; Soyka M
    JAMA; 2018 Aug; 320(8):815-824. PubMed ID: 30167705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Pharmacotherapy Development: Human Clinical Studies.
    Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
    Handb Exp Pharmacol; 2018; 248():579-613. PubMed ID: 29294197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of pharmacotherapy for alcohol use disorder treatment in primary care settings: A scoping review.
    Hyland CJ; McDowell MJ; Bain PA; Huskamp HA; Busch AB
    J Subst Abuse Treat; 2023 Jan; 144():108919. PubMed ID: 36332528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of Alcohol Use Disorder.
    Kranzler HR
    Am J Psychiatry; 2023 Aug; 180(8):565-572. PubMed ID: 37525595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAEM GRACE: Anti-craving medications for alcohol use disorder treatment in the emergency department: A systematic review of direct evidence.
    Punia K; Scott W; Manuja K; Sabbineni M; Campbell K; Balodis IM; MacKillop J
    Acad Emerg Med; 2024 May; 31(5):504-514. PubMed ID: 37735346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.
    Burnette EM; Nieto SJ; Grodin EN; Meredith LR; Hurley B; Miotto K; Gillis AJ; Ray LA
    Drugs; 2022 Feb; 82(3):251-274. PubMed ID: 35133639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
    Williams EC; Matson TE; Harris AHS
    Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapies and personalized medicine for alcohol use disorder: a review.
    Lohoff FW
    Pharmacogenomics; 2020 Oct; 21(15):1117-1138. PubMed ID: 32807012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.
    Falk DE; O'Malley SS; Witkiewitz K; Anton RF; Litten RZ; Slater M; Kranzler HR; Mann KF; Hasin DS; Johnson B; Meulien D; Ryan M; Fertig J;
    JAMA Psychiatry; 2019 Apr; 76(4):374-381. PubMed ID: 30865232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients.
    Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
    Addiction; 2021 Aug; 116(8):1990-1998. PubMed ID: 33394527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies.
    Leggio L; Falk DE; Ryan ML; Fertig J; Litten RZ
    Handb Exp Pharmacol; 2020; 258():443-462. PubMed ID: 31628604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden.
    Månsson A; Danielsson AK; Sjöqvist H; Glatz T; Lundin A; Wallhed Finn S
    Addict Sci Clin Pract; 2024 May; 19(1):41. PubMed ID: 38764075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
    Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
    Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New pharmacotherapies for alcohol dependence.
    Graham R; Wodak AD; Whelan G
    Med J Aust; 2002 Jul; 177(2):103-7. PubMed ID: 12098353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of Evidence-Based Strategies to Treat Alcohol Use Disorder.
    Worley J
    J Psychosoc Nurs Ment Health Serv; 2021 Dec; 59(12):7-11. PubMed ID: 34846245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider?
    Kelty E; Terplan M; Greenland M; Preen D
    Drugs; 2021 May; 81(7):739-748. PubMed ID: 33830479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medications for Alcohol Use Disorder.
    Poorman E; McQuade BM; Messmer S
    Am Fam Physician; 2024 Jan; 109(1):71-78. PubMed ID: 38227873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of policy changes and drug shortages on acamprosate and naltrexone use in Ontario, Canada.
    Konstantelos N; Tourchian N; McCormack D; Lecce P; Tadrous M; Gomes T
    Drug Alcohol Depend; 2023 Jan; 242():109705. PubMed ID: 36463765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.